Shinzo Abe China Japan India city Tokyo Russia covid-19 vaccine patient Coronavirus Shinzo Abe China Japan India city Tokyo Russia

Japan's different problem: It cannot find enough coronavirus patients

Reading now: 370
www.livemint.com

Tokyo: As nations race to develop treatments and vaccines for COVID-19, Japan has become a victim of its own success as slowing new infections has led to a shortage of patients to enroll in clinical trials.

Clinical trials are underway for more than a dozen potential vaccines, including at least six in China, but Japan's first human trials are expected to start next month.In development of treatments, Russia and India approved Fujifilm Holdings Corp's Avigan as a COVID-19 therapy, but Japan, whose Prime Minister Shinzo Abe has touted the drug's potential and hoped to approve it in May, won't see a decision until at least July."Due to the decreasing number of coronavirus infections, we believe it will take some time before clinical research.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA